Total Payments
$43,485
2021 Payments
$5,742
Companies
2
Transactions
92
Medicare Patients
1,910
Medicare Billing
$210,256
Payment Breakdown by Category
Consulting$36,649 (84.3%)
Other$4,600 (10.6%)
Travel$2,112 (4.9%)
Food & Beverage$123.53 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $36,649 | 79 | 84.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,600 | 5 | 10.6% |
| Travel and Lodging | $2,112 | 7 | 4.9% |
| Food and Beverage | $123.53 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $43,362 | 91 | $0 (2021) |
| Mallinckrodt LLC | $123.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $5,742 | 15 | NOVARTIS PHARMACEUTICALS CORPORATION ($5,742) |
| 2020 | $6,051 | 17 | Novartis Pharmaceuticals Corporation ($6,051) |
| 2019 | $5,226 | 13 | Novartis Pharmaceuticals Corporation ($5,226) |
| 2018 | $15,981 | 30 | Novartis Pharmaceuticals Corporation ($15,981) |
| 2017 | $10,486 | 17 | Novartis Pharmaceuticals Corporation ($10,362) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $189.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $148.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $167.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $117.60 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $175.32 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $109.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $30.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $34.16 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $70.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $5.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2020 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2020 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $48.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $215.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $89.79 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $20.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 223 | 359 | $60,108 | $23,891 |
| 2022 | 6 | 535 | 937 | $160,678 | $58,756 |
| 2021 | 9 | 572 | 1,007 | $164,981 | $62,960 |
| 2020 | 8 | 580 | 1,073 | $167,543 | $64,649 |
Total Patients
1,910
Total Services
3,376
Medicare Billing
$210,256
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 195 | $26,910 | $11,183 | 41.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 53 | $10,547 | $4,605 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 58 | 59 | $11,918 | $4,127 | 34.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,432 | $1,750 | 32.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 19 | 19 | $3,876 | $1,528 | 39.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 19 | $1,425 | $697.87 | 49.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 203 | 510 | $70,380 | $25,865 | 36.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 103 | 169 | $33,631 | $12,471 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 124 | 151 | $30,502 | $10,705 | 35.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 67 | 69 | $14,076 | $5,413 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $8,924 | $3,148 | 35.3% |
| 99358 | Extended patient service without direct patient contact, first hour | Facility | 2022 | 15 | 15 | $3,165 | $1,155 | 36.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 223 | 546 | $75,540 | $28,475 | 37.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 104 | 190 | $37,883 | $14,852 | 39.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 78 | 80 | $16,320 | $6,418 | 39.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 50 | 60 | $12,120 | $4,375 | 36.1% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 42 | 53 | $7,367 | $2,719 | 36.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $6,596 | $2,574 | 39.0% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2021 | 20 | 20 | $4,220 | $1,687 | 40.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 27 | 30 | $4,110 | $1,541 | 37.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 11 | $825.00 | $320.32 | 38.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 299 | 705 | $97,290 | $37,674 | 38.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 99 | 150 | $29,850 | $11,880 | 39.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 71 | 72 | $14,688 | $5,821 | 39.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 27 | 28 | $10,864 | $4,124 | 38.0% |
About Dr. Christopher Hoffman, MD
Dr. Christopher Hoffman, MD is a Hospitalist healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114966835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Hoffman, MD has received a total of $43,485 in payments from pharmaceutical and medical device companies, with $5,742 received in 2021. These payments were reported across 92 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($36,649).
As a Medicare-enrolled provider, Hoffman has provided services to 1,910 Medicare beneficiaries, totaling 3,376 services with total Medicare billing of $210,256. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Family Medicine
- Location Nashville, TN
- Active Since 06/06/2006
- Last Updated 08/06/2021
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1114966835
Products in Payments
- GILENYA (Drug) $39,339
- MAYZENT (Drug) $4,022
- OFIRMEV (Drug) $123.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Nashville
Dr. Olalekan Oluwole, Md, Mph, MD, MPH
Hospitalist — Payments: $219,617
Hospitalist $219,617
Andrew Zurick, M.d, M.D
Hospitalist — Payments: $171,446
Hospitalist $171,446
Dr. Sonya Reid, Md, MD
Hospitalist — Payments: $99,563
Hospitalist $99,563
Ravi Mishra, Md, MD
Hospitalist — Payments: $6,123
Hospitalist $6,123
Courtney Havill, Fnp-C, FNP-C
Hospitalist — Payments: $3,934
Hospitalist $3,934
Philip Kuo, Md, MD
Hospitalist — Payments: $3,825
Hospitalist $3,825